Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

2.01
Delayed Data
As of Aug 26
 -0.005 / -0.25%
Today’s Change
0.80
Today|||52-Week Range
8.96
+65.70%
Year-to-Date

Today’s Trading

Previous close2.01
Today’s open2.05
Day’s range2.00 - 2.05
Volume132,443
Average volume (3 months)600,792
Market cap$48.8M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+42.92%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.63

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc-0.11-2.54%
AXNAoxing Pharmaceutica...+0.01+0.79%
MTEXMannatech Inc+0.94+5.61%
PRANPrana Biotechnology ...-0.03-0.56%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts

Partner Offers

Search for Jobs